CATALYST FINANCIAL PARTNERS LLC

Position in DHR — Danaher Corp /De/

CIK 1927537 BOSTON, MA

Position in DHR

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$835,254

+$78,561 QoQ

Shares Held

4,385

+9.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,157

of 2,098 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $2,429,052 across 4 Diagnostics & Research names. DHR ranks #2 (34.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	2,272	$1,139,089
2	DHR	Danaher Corp /De/ This page	4,385	$835,254
3	IDXX	Idexx Laboratories Inc /De	456	$240,056
4	A	Agilent Technologies, Inc.	1,616	$214,653

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$835,254	4,385	+9.9%	Shares	Sole	2026-07-30
2026-03-31	$756,693	3,991	+2.9%	Shares	Sole	2026-05-12
2025-12-31	$887,980	3,879	+6.4%	Shares	Sole	2026-02-04
2025-09-30	$722,855	3,646	-2.9%	Shares	Sole	2025-11-12
2025-06-30	$741,367	3,753	-2.7%	Shares	Sole	2025-08-14
2025-03-31	$790,480	3,856	+4.0%	Shares	Sole	2025-05-02
2024-12-31	$850,941	3,707	-2.5%	Shares	Sole	2025-01-30
2024-09-30	$1,057,032	3,802	-0.5%	Shares	Sole	2024-10-28
2024-06-30	$954,926	3,822	+7.0%	Shares	Sole	2024-07-25
2024-03-31	$892,249	3,573	+10.2%	Shares	Sole	2024-04-23
2023-12-31	$750,235	3,243	+1.6%	Shares	Sole	2024-02-07
2023-09-30	$791,687	3,191	+19.2%	Shares	Sole	2023-10-26
2023-06-30	$642,240	2,676	+13.4%	Shares	Sole	2023-08-02
2023-03-31	$594,814	2,360	-5.4%	Shares	Sole	2023-04-11
2022-12-31	$661,957	2,494	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.